Ensweet
FranceEntry
2025
Hold
1yr
Status
Active
Who owns Ensweet?
Ensweet is a French HealthTech company, currently owned by XAnge since 2025 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key takeaways
- ·Co-held by IRD Invest, Finovam Gestion, 50 Partners and XAnge since 2022.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2022 · present
IRD InvestActive
2022 · present(4yr) · Nord Création · 2002 · Evergreen
Finovam GestionActive
2023 · present(3yr) · FIRA Nord-Est 2 · 2021 · VC
50 PartnersActive
2024 · present(2yr) · 50 Partners Capital Health · 2022 · VC
XAngeActive
2025 · present(1yr) · XAnge 5 · 2025 · VC
More from XAnge 5
Other portfolio companies in the same fund.
Germany
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
UK
US
Questions
Who owns Ensweet?
Ensweet is currently owned by XAnge, 50 Partners and 2 others, through XAnge 5, since 2025.
When did XAnge and 3 others acquire Ensweet?
XAnge and 3 others acquired Ensweet in 2025.
Who has owned Ensweet over time?
Ensweet has been through 4 private-equity ownership periods: IRD Invest · via Nord Création · since 2022; Finovam Gestion · via FIRA Nord-Est 2 · since 2023; 50 Partners · via 50 Partners Capital Health · since 2024; XAnge · via XAnge 5 · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue